The HIV/AIDS epidemic: Its evolutionary implications for human ecology with special reference to the immune system

Science of the Total Environment

Volumn 191, Issue 3, 1996, Pages 245-269

  Caldararo, Niccolo ^a  

^a SAN FRANCISCO STATE UNIVERSITY   (United States)

Author keywords

Africa; AIDS; cultural practices; evolution; heterosexual; immune system

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AFRICA; ARTICLE; CULTURAL FACTOR; ECOLOGY; EVOLUTION; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE SYSTEM; PRIORITY JOURNAL; SEXUAL TRANSMISSION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; AFRICA; ANTIBODIES, VIRAL; AUTOIMMUNE DISEASES; FEMALE; HAITI; HIV INFECTIONS; HUMANS; LIFE STYLE; MALE; NEEDLE SHARING; RETROVIRIDAE INFECTIONS; SEXUALLY TRANSMITTED DISEASES; STERILIZATION;

HUMAN IMMUNODEFICIENCY VIRUS; UNIDENTIFIED RETROVIRUS;

EID: 0030598370     PISSN: 00489697     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0048-9697(96)05267-9     Document Type: Article

References (299)

1. [1] Harper, R.M.J. Evolutionary origins of disease, 1975.
2. [2] Ewald, P.W. Evolution of infectious disease, Oxford University Press, Oxford, 1993.
3. [3] Stastny, P. HL-A antigens in mummified Pre-Columbian tissues. Science, 183 (1974) 864-867.
4. [4] Wallace, B. Genetic Load. Englewood Cliffs: Prentice-Hall, 1970.
5. [5] Merbs, C.F. A new world of infectious disease, Yr. Phys. Anth., 35 (1992) 3-42.
6. [6] De Hovitz, J.A. A perspective on the heterosexual transmission of the acquired immunodeficiency syndrome. NY State J. Med., 86 (1986) 117-118.
7. [7] Imperato, P.J. The epidemiology of the Acquired Immunodeficiency Syndrome in Africa. NY State J. Med., 86 (1986) 118-121.
8. [8] Curran, J.W., Morgan, W.M., Hardy, A.M., Jaffe, H.W., Darrow, W.W. and Dowdle, W.R. The epidemiology of AIDS: current status and future prospects. Science 229 (1985) 1352-1357. Med. J. 1988.
9. [9] May, R.M. and Anderson, R.M. Transmission dynamics of HIV infection. Nature, 326 (1987) 137-142.
10. [10] Barre-Sinoussi, F., Rey, F., Nugeyre, T. et al. Retrovirus from a patient at risk for Acquired Immune Deficiency Syndrome (AIDS). Science, 220 (1983) 868-871.
11. [11] Gallo, R.C., Sarin, P.S. and Gelmann, E.P. Isolation of Human T-cell Leukemia Virus in Acquired Immune Deficiency Syndrome (AIDS). Science, 220 (1983) 865-867.
12. [12] Popovic, M., Sarngadharan, M.G., Read, E. and Gallo, R.C. Detection, isolation, and continuous production of cytopathic retroviruses (GTLV-III) from patients with AIDS and Pre-AIDS. Science, 224 (1984) 497-500.
13. [13] Schupbach, J., Popovic, M., Gliden, R.V., Gonda, M.A., Sarngadharan, M.G. and Gallo, R.C. Frequent detection and isolation of cytopathic retroviruses from patients with AIDS and at risk for AIDS. Science, 224 (1984) 500-505.
14. [14] Levy, J.A., Kaminsky, L.S., Morrow, W.J.W. et al. Infection by the retrovirus associated with Acquired Immune Deficiency Syndrome. Ann. Intern. Med., 103 (1985) 694-699.
15. [15] Mayer, K.H., Ayotte, D., Groopman, J.E., Stoodard, A.M., Sarngadharan, M. and Gallo, R. Association of human T lymphotropic virus type III antibodies with sexual and other behaviors in a cohort of homosexual men from Boston with and without generalized lymphadenopathy. Am. J. Med., 80 (1986) 357-363.
16. [16] Curran, J.W., Lawrence, D.M., Jaffe, H., Kaplan, J., Zyla, L.D. and Chamberland, M. Acquired immunodeficiency syndrome associated with transfusion. N. Engl. J. Med., 310 (1984) 69-75.
17. [17] Melbye, M., Bayley, A., Manuwele, J.K. et al. Evidence of heterosexual transmission and clinical manifestations of human immunodeficiency virus infection and related conditions in Lusaka, Zambia. Lancet, 1986, pp. 1113-1115.
18. [18] Minkin, S.F. Iatronic AIDS: unsafe medical practices and the HIV epidemic. Soc. Sci. Med., 33 (1991) 7, 786-790.
19. [19] Hrdy, D.B. Cultural practices contributing to the transmission of Human Immunodeficiency Virus in Africa. Rev. Infect. Dis., 9 (1987) 6, 1109-1119.
20. [20] Pela, O.A. and Platt, J.J. AIDS in Africa: emerging trends. Soc. Sci. Med., 28 (1989) 1, 1-8.
21. [21] Packard, R.M., Epstein, P. Epidemiologists, social scientists and the structure of medical research on AIDS in Africa. Soc. Sci. Med., 33 (1991) 7, 771-794.
22. [22] Hoffman, G.W., Kion, T.A., Grant, M.D. An idiotypic network model of AIDS immunopathogenesis. Proc. Natl. Acad. Sci., 88 (1991) 3060-3064.
23. [23] Kion, T.A., Hoffman, G.W. Anti-HIV and anti-antiMHC antibodies in alloimmune and autoimmune mice. Science, 253 (1991) 1138-1140.
24. [24] Elswood, B., Stricker, R. and Neves, W. AIDS: why is science failing. J. Tarde (Sao Paulo). Oct. 12, 1991.
25. [25] Maddox, J. AIDS research turned upside down. Nature, 353 (1991) 297.
26. [26] Larson, A. The social epidemiology of Africa's AIDS epidemic. African Affairs, 89 (1990) 354, 5-25.
27. [27] Morse, S.S. 'Crossing over: the interspecies traffic of emerging infections', J. HIH Res., Vol. 6, Oct. 1994, pp. 52-56.
28. [28] Morse, S.S. (Ed.), The Evolutionary Biology of Viruses, Raven Press, 1994.
29. [29] Caldararo, N.L. Anthropological interpretation, human ecological perspectives and the role of forest fires in human evolution. In: A Living Anthropology in Service to the World, Preprints, Second Annual Symposium, CIIS, 1996, pp. 58-70.
30. [30] Caldwell, J.C. and Caldwell, P. 'The African AIDS epidemic', Scientific American, March 1996, 62-68.
31. [31] Linke, U. AIDS in Africa. Science, 231 (1986) 203.
32. [32] Burton, M.L. AIDS and female circumcision. Science, 231 (1986) 1236.
33. [33] Hayes, R.O. Female genital mutilation, fertility control, women's roles, and the patrilineage in modern Sudan: a functional analysis. Am. Ethnol., 2 (1975) 4, 617-633.
34. [34] Burton, M.L. Personal Communication, 1986.
35. [35] Hosken, F.P. The violence of power: the gential mutilation of females. Heresies, 6 (1978) 28-36; Hosken, F.P. The epidemiology of female genital mutilations. Tropical Doctor, 1978, pp. 150-156.
36. [35] Hosken, F.P. The violence of power: the gential mutilation of females. Heresies, 6 (1978) 28-36; Hosken, F.P. The epidemiology of female genital mutilations. Tropical Doctor, 1978, pp. 150-156.
37. [36] Verzin, J.A. Sequelas of female circumcision. Tropical Doctor, 5 (1975) 163-169.
38. [37] Dewurst, C. and Michelson, A. Infibulation complicating pregnancy. Brit. Med. J., 2 (1964) 1412-1413.
39. [38] De Villeneuve, A. Etude sur une coutume somalie: les femme cousues. Journal de la Societe des Africanistes, 4 (1973) 15-32.
40. [39] Pieters, G. Gynaecology in the country of the sewn women. Acta Chir. Belg., 3 (1972) 173-193. See also, Win News, 2 (1976) 3, 19.
41. [39] Pieters, G. Gynaecology in the country of the sewn women. Acta Chir. Belg., 3 (1972) 173-193. See also, Win News, 2 (1976) 3, 19.
42. [40] Cook, R. Damage to physical health from Pharonic circumcision (infibulation) of females; a review of medical literature. (Regional MCH/NUT Adviser) WHO, Eastern Mediterranean Region, 1976 (cyclostyled).
43. [41] Gasim, B. The views of Sudanese gynecologists, midwives and college students on female circumcision. WHO/EMRO Tech. Pub. 2 (1982) 300-311, Alexandria, WHO.
44. [42] Taba, A.H. Female circumcision. World Health, WHO, May 1979.
45. [43] Hussein, F.M.H., Shah, H.P., Hasir, S. et al. Community study on female circumcision in Somalia. Intermediate and late health hazards. WHO/EMRO Tech. Pub. 2 (1982) 278-299, Alexandria, WHO.
46. [44] Nelson, N. 'Selling her Kiosk': Kikuyu notions of sexuality and sex for sale in Mathare Valley, Kenya. In: Caplan, P. (Ed.), The Cultural Construction of Sexuality. Tavistock Publications, London, 1987, pp. 217-239.
47. [45] Hosken, F.P. Genital mutilation of women in Africa. Munger Africana Library Notes, issue 36, Oct. 1976, California Institute of Technology and Personal Communication, 1986.
48. [46] Huber, A. Weibliche zirkumzision und infibulation in Athiopien. Acta Tropica, 1966, pp. 87-91.
49. [47] Silberstein, A.J. Circoncision feminine en Cote d'Ivorie. Ann. Soc. Belg. Med. Trop., 57 (1977) 3, 129-135.
50. [48] Widstrand, C.G. Female infibulation. Studia Ethnographica Upsaliensia, 20 (1965) 95-124.
51. [49] Abdalla, R.H.D. Sisters in Affliction: Circumcision and infibulation of women in Africa. Zed. Press, London, 1982.
52. [50] Kennedy, J.G. Circumcision and excision in Egyptian Nubia. Man., 5 (1970) 2, 175-191.
53. [51] Lightfoot-Klein, H. Prisoners of Ritual: An Odyssey into Female Genital Circumcision in Africa, Haworth Press, NY, 1989.
54. [52] Gallo, P. Views of future health workers in Somalia on female circumcision. Med. Anthropol. Ort., 17 (1986) 3, 71-73.
55. [53] Evatis-Pritchard, E.E. The Muer., 1940.
56. [54] Huntingford, G.W.B. The Nandi of Kenya, 1953.
57. [55] Huntingford, G.W.B. The Northern Nilo-Hamites, 1953.
58. [56] Texttor, R.B. A Cross-Cultural Summary, HRAF Press, New Haven, 1967, p. 377.
59. [57] Dawson, M.H. Health nutrition and population in Central Kenya, 1890-1945. In: Cordell, D.D. and Gregory, J.W. (Eds.), African Population and Capitalism: A historical Perspective. Westview Press, London, 1987, pp. 201-220.
60. [58] Romberg, R. Circumcision: The Painful Dilemma. Bergin and Garvey, Mass, 1985.
61. [59] Paige, K.E., Paige, J.M. The Politics of Reproductive Ritual, University of California Press, Berkeley, 1981.
62. [60] Moore, A., LeBaron, R.D. The case for a Haitian origin of the AIDS epidemic. In: Feldman, D. and Johnson, T.M. (Eds.), The Social Dimensions of AIDS. Praeger, New York, 1986, pp. 77-93.
63. [61] Simonson, J.N., Cameron, D.W., Gakinya, M. et al. Human Immunodeficiency Virus infection among men with sexually transmitted diseases. N. Engl. J. Med., 319 (1988) 5, 274-278.
64. [62] Mbugua, G.G., Muthami, L.N., Mutura, C.W. et al. 'Epidemiology of HIV infection among long distance truck drivers in Kenya', East African Med. J., Vol. 72, 8 (1995) 514-518.
65. [63] Carswell, J.W., Lloyd, G. and Howells, J. 'Prevalence of HIV in East African lorry drivers', AIDS, 3 (1989) 759-761.
66. [64] Hoebel, E., Adamson, Anthropology: The Study of Man, 3rd Edition, McGraw-Hill, New York, 1966.
67. [65] DeMeo, J., On the Origins and Diffusion of Patrism: The Saharasian Connection, 1986.
68. [66] Mann, J.M., Davachi, F., Quinn, T.C. et al. Risk factors for Human Immunodeficiency Virus seropositivity among children 1 to 24 months old in Kinshasa, Zaire. Lancet, 1986, 654-656.
69. [67] Lepage, P., Vande Perre, P., Carael, M. and Butzler, J.P. Are medical injections a risk factor for HIV infection in children? Lancet. 1986, 1103-1104.
70. [68] Coll, Awa. First international workshop on Women and AIDS in Africa, 1989, Harare Zimbabwe. Reported in AIDS and Society, October, 1989. p, 16.
71. [69] Basilico, C. Report from the AIDS/Poliovirus Advisory Commitee to the Wistar Institute. Wistar Institute, Philiadelphia, Pa. October, 1992.
72. [70] Ohta, Y., Tsujimoto. H., Ishikawa, K. et al. No evidence for the contamination of live oral poliomyelitis vaccines with simian immunodeficiency virus. AIDS, 3 (1989) 183-185.
73. [71] Siegal, F.P. and Siegal, M. AIDS: The Medical Mystery. New York. Grove Press, 1983 p. 84.
74. [72] Melbye, M., Biggar, R.J. and Ebbesen, P. Epidemiology: Europe and Africa. In: Ebbesen, P., Biggar, R.J. and Melbye, M. eds, AIDS, A Basic Guide for Clinicians. W.B. Saunders, Philadelphia, 1984, pp. 29-41.
75. [73] Leibowitch, J. A Strange Virus of Unknown Origin, Available Press, 1985.
76. [74] Fettner, A.G. and Check, W.A. The Truth About AIDS: Evolution of an Epidemic. Holt, Rinehart and Winston, NY, 1984, pp. 104-124.
77. [75] Selzer, R. A mask on the face of death. Life, 10 (1987) 58-64.
78. [76] Herskovits, M.J. Life in a Haitian Valley. New York, Double-day/Anchor (originally published in 1937), 1971; Metraux, A. Le Vaudou Haitien. Paris, Gallimard, 1958.
79. [76] Herskovits, M.J. Life in a Haitian Valley. New York, Double-day/Anchor (originally published in 1937), 1971; Metraux, A. Le Vaudou Haitien. Paris, Gallimard, 1958.
80. [77] Picoche, M. Origenes Del Pueblo Haitiano. Historia y Folklore Africano en America, Cuadernos de Trabajo, Departmento de Etnologia y Antropologia Social, Instituto Nacional de Antropologia e Historia, Mexico, D.F., Agosto, 27 (1980) 1-48.
81. [78] Taylor, C.C. 'Condoms and cosmology: the fractal person and sexual risk in Rwanda', Paper delivered at the American Antropological Association Meetings, 1988.
82. [79] Quinn, T.C., Mann, J.M., Curran, J.W. and Piot, P. AIDS in Africa: an epidemiologic paradigm. Science, 234 (1986) 955-963.
83. [80] Roberts, Allen F. Anarchy, abjection and absurdity: a case of metaphoric medicine among the Tabwa and Zaire. In: Lola Romanucci-Ross, Daniel E. Moerman and Laurence R. Tancredi, (Eds.), The Anthropology of Medicine: from Culture to Method, Praeger, New York, 1983, pp. 119-133.
84. [81] Courouce, A., Miller, J., Richard, D. False-positive Western Blot reactions to Human Immunodeficiency Virus in blood donors. Lancet, 1986, pp. 921-922.
85. [82] Biberfeld, G., Gredberg-Raden, U., Bottinger, B., Putkonen, P., Blomberg, J., Juto, P. and Wadell, G. Blood donor sera with false-positive Western Blot reactions to Human Immunodefiency Virus. Lancet, 1986, pp. 289-290.
86. [83] Van Der Poel, C.L., Reesink, H.W., Tersmette, T., Lelie, P.N., Huisman, H. and Miedema, F. Blood donations reactive for HIV in Western Blot, but non-infective in culture and recipients of blood. Lancet. 1986, pp. 752-753.
87. [84] Bedariada, G., Cambie, G., D'Agostino, F. et al. HIV IgM antibodies in risk groups who are seronegative on ELISA testing. Lancet. 1986, pp. 570-571.
88. [85] Karpas, A., Maayaan, S., Raz, R. Lack of antibodies to adult T-cell leukaemia virus and to AIDS virus in Isreali Falashas. Nature, 319 (1986) 794.
89. [86] Gallo, D., Diggs, J.L., Shell, G.R., Daily, P.J., Hoffman, M.N. and Riggs, J.L. Comparison of detection of antibody to the Acquired Immune Deficiency Syndrome Virus by Enzyme Immunoassay, Immune-fluorescence, and Western Blot methods. J. Clin. Microbiol., 23 (1986) 6, 1049-1051.
90. [87] Blumberg, R.S., Sandstrom, E.G., Paradis, T.J., Neumeyer, D.N., Sarngadharan, M.G., Hartshorn, K.L., Byington, R.E., Hirsch, M.S. and Schooley, R.T. Detection in human T-cell lymphotropic Virus type III-related antigens and anti-human T-cell lymphotropic Virus type-III antibodies by anticomplementary immunofluroescence. J. Clin. Microbiol., 23 (1986) 6, 1072-1077.
91. [88] Mboup, S., Richard, D., Boye, C. et al. Striking the balance on AIDS. Nature, 326 (1987) 734.
92. [89] Barnes, D.M. New questions about AIDS test accuracy. Science, 238 (1987) 884-885.
93. [90] Michail-Merianou, V. Tzivaras, A., Piperi-Lowes, L., Kattamis, C., Ladis, V. and Papadakou-Lagogianni, R. False-positive HTLV-III antibody tests in multitransfused patients with Thalassaemia. Lancet, 1986, p. 687.
94. [91] Wendler, I., Schnedier, J., Gras, B., Fleming, A.F., Hunsmann, G. and Schmitz, H. Seroepidemiology of Human Immunodeficiency Virus in Africa. Brit. Med. J. 293 (1986) 782-785.
95. [92] Biggar, R.J., Gigase, P.L., Melbye, M. et al. Elisa HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. 1985, pp. 520-523; Biggar, R.J. The AIDS problem in Africa. Lancet., 1986, pp. 79-84.
96. [92] Biggar, R.J., Gigase, P.L., Melbye, M. et al. Elisa HTLV retrovirus antibody reactivity associated with malaria and immune complexes in healthy Africans. Lancet. 1985, pp. 520-523; Biggar, R.J. The AIDS problem in Africa. Lancet., 1986, pp. 79-84.
97. [93] Fleming, A.F., Kazi, A.R., Schneider, J. et al. Comparison of H9/HTLV-III and ENV-80 ELISAs as screening tools in Tropical Africa: prevalence of anti-LAV/HTLV-III in some Zambian patients. AIDS-Forschung (AIFO), 8 (1986) 434-440.
98. [94] Courouce, A.M., Benhamou, E., Devailly, J. and Chamaret, S. Comparison of commerical kits for the detection of anti-LAV antibodies in blood donors. In: Gluckman, J.C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Paris, Elsevier, 1987, pp. 183-188; Alter, H.J. Transmission of LAV/HTLV-III by blood products. Ibid: 159-166.
99. [94] Courouce, A.M., Benhamou, E., Devailly, J. and Chamaret, S. Comparison of commerical kits for the detection of anti-LAV antibodies in blood donors. In: Gluckman, J.C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Paris, Elsevier, 1987, pp. 183-188; Alter, H.J. Transmission of LAV/HTLV-III by blood products. Ibid: 159-166.
100. [95] Mann, J.M. The epidemiology of LAV/HTLV-III in Africa. In: Gluckman, J.C. and Vilmer, E. (Eds)., Acquired Immunodeficiency Syndrome. Paris, Elsevier, 1987, pp. 131-136.
101. [96] Konotey-Ahulu, FID. Clinical epidemiology, not seroepidemiology, is the answer to Africa's AIDS problem. Bri. Med. J., 294 (1987) 1593-1594.
102. [97] Acheson, E.D. AIDS: a challenge for the public helath. Lancet, (1986) 662-666.
103. [98] Azocar, J., Martinez, C., McLane, M.F., Allan, J., Essex, M. Lack of endemic HIV infection in Venezuela. AIDS Res. Human Retro, 3 (1987) 2, 107-108.
104. [99] Volsky, D.J., Rodriguez, L., Dewhurst, S. et al. Antibodies to Acquired Immune Deficiency Syndrome (AIDS)-Associated Virus (HTLV-III/LAV) in Venezuelan populations. AIDS Res. Human Retro, 2 (1986) 2, 79-92.
105. [100] Rodriguez, L., Dewhurst, S., Sinangil, F., Merino, F., Godoy, G. and Volsky, D.J. Natural anitbodies to HTLV-III/LAV among aboriginal Amazonia Indians in Venezuela. Lancet, (1985) 1098-1100.
106. [101] Mendelhall, C.L., Roselle, G.A., Grossman, C.J. et al. False-positive tests for HIV-I antibodies in alcoholic patients with hepatitis. N. Engl. J. Med. 314 (1986) 921-922.
107. [102] Fleming, D., Cochi, S.L., Steece, R.S. and Hull, H.F. Acquired Immunodificiency Syndrome in low-incidence areas. J. Am.Med. Assoc., 258 (1987) 6, 785-787.
108. [103] Schubach, J. and Tanner, M. Specificity of Human Immunodeficiency Virus (LAV/HTLV-III)-reactive antibodies in African sera from southeastern Tanzania. Acta Tropica, 43 (1986) 195-206.
109. [104] Peterson, N.C., Ho, E.W., Brown, M.L., Yamamoto, J.K. Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome. Science, 235 (1987) 790-793.
110. [105] Eigen, M., Viral quasispecies, Sci. Am., 269 (1993) 1, 42-48.
111. [106] Lo, S., Wai-Kuo Shih, J., Yang, N. et al. A novel virus-like infectious agent in patients with AIDS. Am. J. Trop. Med. Hyg., 40 (1989) 2, 218-226.
112. [107] Wright, K. Mycoplasmas in the AIDS spotlight. Science, (1990) 682-683.
113. [108] Di Gurado, G. HIV and mycoplasma-associated disease: are animal lentiviruses and mycoplasmal infections a reference model? Res. Virol., 142 (1991) 71-72.
114. [109] Jansson, E., Wegelius, R., Hakkarainen, K., Miettinen, A. Mycoplasmas and leukaemia. Res. Virol., 142 (1991) 333.
115. [110] Molbak, K., Laurtizen, E., Fernandes, D., Bottiger, B. and Biberfeld, G. Antibodies to HTLV-IV associated with chronic, fatal illness resembling 'slim disease', Lancet, 1986, pp. 1214-1215.
116. [111] Clavel, F., Guetard, D., Brun-Vezinet, F. et al. Isolation of a new human retrovirus from West African patients with AIDS. Science, 343 (1986) 223-246.
117. [112] Kornfeld, H., Riedel, N., Viglianti, G.A., Hirsch, V. and Mullins, J.I. Cloning of HTLV-IV and its relation to Simian and Human Immunodefiency Viruses. Nature, 326 (1987) 610-613.
118. [113] Murphey-Corb, M., Martin, L.N., Rangan, S.R.S. et al. Isolation of an HTLV-III-related retrovirus from macaques with simian AIDS and its possible origin in asymptomatic mangabeys. Nature, 321 (1986) 435-437.
119. [114] Huet, T., Cheynier, R., Meyerhans, A. et al. Genetic organization of a chimpanzee lentivirus related to HIV-1. Nature, 345 (1990) 356-359.
120. [115] Ishida, T. and Hinuma, Y. The origin of HTLV-1. Nature, 322 (1986) 504.
121. [116] Saksena, N.K., Sherman, M.P., Yanagihara, R., Dube, D.K., and Poiesz, B.J., LTR sequence and phylogentic analysis of a newly discovered variant of HTLV-1 isolated from the Hagahai of Papua New Guinea, Virology, 189(1) (1992) 1-9.
122. [117] Vandamme, A.M., Liu, H.F., Goubau, P. and Desmyter, J., Primate T-lymphotropic virus type 1 LTR sequence variation and its phylogenetic analysis: compatibility with an African origin of PTLV-1, Virology, 202(1) (1994) 212-223.
123. [118] Switzer, W.M., Black, F.L., Pieniazek, D. et al. Endemicity and phylogeny of the Human T-cell lymphotropic virus type II subtype A from the Kayapo Indians of Brazil: Evidence for limited regional dissemination, AIDS Res. Human Retroviruses, 12(7) (1996) 635-639.
124. [119] Chen, Y.-M. A., Kanki, P.J., Jang, Y.-J. et al. Isolation of Simian T-lymphotropic virus type II (STLV-II) from New World Monkeys, Abstr. Papers 1995 Symp. Retroviruses, Cold Spring Harbor Laboratory, 1995, p. 2.
125. [120] Hemming, J. Red Gold, The Conquest of the Brazilian Indians, 1500-1760, Harvard University Press, Cambridge, 1978.
126. [121] Prince, A., Pascual, M., Kosolapov, L.B. et al. Prevalence, clinical significance, and strain specificity of neutralizing antibody to the Human Immuno-deficiency Virus. J. Infect. Dis., 156 (1987) 268-272.
127. [122] Chiodi, F., Fenyo, E.M., Albert, J. and Asjo, B., Human Immunodeficiency Virus isolates differ in replication potential in vitro, Cold Spring Harbor Symp. Retroviruses, Abstr., 1987, p. 147.
128. [123] Conn, Jon, Controversy: is KS really caused by new herpesvirus?, Science, 268 (1995) 1847-1848.
129. [124] Wong-Staal, F., Shaw, G.M., Hahn, B.H. et al. Genomic diversity of Human T-Lymphotropic Virus type III, HTLV-III. Science, 229 (1985) 759-762.
130. [125] Hahn, B.H., Shaw, G.M., Taylor, M.E. et al. Genetic variation in HTLV-III/LAV over time in patients with AIDS or at risk for AIDS. Science, 232 (1986) 1549-1553.
131. [126] Minis, C.A. and White, D.O., Viral Pathogenesis and Immunology. Blackwell Scientific Publications, Oxford, 1984.
132. [127] Miedema, F. and Klein, M.R., AIDS pathogenesis: a finite immune response to blame?'. Science, 272 (1996) 505-506.
133. [128] Rosenberger, D.F., Werner, P.A., Steinman, R. et al. Group specific component (GC) and HIV disease. Disease Markers 6(4) (1988) 269-274.
134. [129] Eales, L.J., Parkin, J.M., Forester, S.M. et al. Association of different allelic forms of group specific component with susceptibility to and clinical manifestation of Human Immunodeficiency Virus infection. Lancet, (1987) 99-1002.
135. [130] Taylor, R., Histocompatibility antigens, protective immunity, and HIV-1', J. NIH Res., 6 (1994) 68-71.
136. [131] Martinez, A.C., De la Hera, A., Alonso, J.M., et al. Immunological consequences of HIV infection: advantage of being low responder cast doubts on vaccine development. Lancet, (1988) 454-457.
137. [132] Baiter, M., Elusive HIV-suppressor factors found', Science, 270 (1995) 1560-1561.
138. [133] Fauci, A.S., Masur, M.D., Gelmann, E.P. et al. The Acquired Immunodeficiency Syndrome: an update. Ann. Int. Med., 102 (1985) 800-813.
139. [134] Mann, J.M., Colebunders, R.L., Khonde, N. et al. Natural history of Human Immunodeficiency Virus infection in Zaire. Lancet, (1986) 707-709.
140. [135] Mann, J.M., Quinn, T.C., Francis, H. et al. Prevalence of HTLV-III? LAV in household contracts of patients with confirmed AIDS and controls in Kinshasa, Zaire. J. Am. Med. Assoc., 256 (1986) 6721-6724.
141. [136] Khalife, J., Guy, B., Capron, M. et al. Isotypic restriction of the antibody response to HIV. AIDS Res. Human Retro viruses., 4 (1988) 1, 3-9.
142. [137] Nixon, D.F., Eglin, R.P., Westwood, S.A., Werrett, D.J. and Rizza, C.R. Group-specific component and HIV infection. Lancet, (1987) 39-40.
143. [138] Jacob, L., Maisonneuve, P., Sereni, D., Sultan, Y., Laroche, C. and Gazengel, C. Possible genetic susceptibility to the Acquired Immunodeficiency Syndrome in hemophiliacs. Ann. Int. Med. 104 (1986) 1, 130.
144. [139] Klitz, W. Viruses, cancer and the MHC. Nature, 356 (1992) 17-18.
145. [140] McCormack, J.E., Kappler, J. and Marrack, P., Stimulation with specific antigen can block superantigen-mediated deletion of T-cells in vivo. Proc. Natl. Acad. Sci. USA, 91 (1994) 2086-2090.
146. [141] Weiss, R.A. How does HIV cause AIDS? Science, 260 (1993) 1273-1279.
147. [142] Coffin, J.M. Superantigens and endogenous retroviruses: a confluence of puzzles. Science, 255 (1992) 411-413.
148. [143] Imberti, L., Sottini, A., Bettinardi, A., Puoti, M. and Primi, D. Selective depletion in HIV infection of T-cells that bear specific T-celt receptor V 9β sequences. Science, 254 (1991) 860-862.
149. [144] Gougeon, M.L. and Montagnier, L. Apoptosis in AIDS. Science, 260 (1993) 1269-1270.
150. [145] Kiprov, D.D., Sheppard, H.W. and Hanson, C.V. Alloimmunization to prevent AIDS? Letter, Science, 263 (1994) 737-738.
151. [146] Honjo, T., Seppuku and autoimmunity. Science, 258 (1992) 591-592.
152. [147] Oltvai, Z.N. and Korsmeyer, S.J., Checkpoints of duelling dimers foil death wishes. Cell, 79(2) (1994) 189-192.
153. [148] Hockmeyer, S.J., Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell, 75(2) (1993) 241-251.
154. [149] Li, C.J., Friedman, D.J., Wang, C., Metelev, V. and Pardee, A.B., Induction of apoptosis in unifected lymphocytes by HIV-1 Tat protein. Science, 268 (1995) 429-432.
155. [150] Forte, S.E., Mohan, S., Sullivan, J.L. and Somasundaran, M., A mechanism for HIV-1 cytopathogenicity involves mitochondria, Abstr., Cold Spring Harbor, Symp. Retroviruses, 1995, p. 50.
156. [151] Boise, L.H., Gonzalez-Garcia, M., Postema, C.E., Ding, L., Lindsten, T. et al. Bcl-x, a Bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell, 74(4) (1993) 597-608.
157. [152] Anderson, K.C., Gorgone, B.C., Marlink, R.G. et al. Transfusion-acquired Human Immunodeficiency Virus infection among immunocompromized persons. Ann. Int. Med. 105 (1986) 5, 519-527.
158. [153] Bloom, A.L. AIDS in haemophiliacs and homosexuals. Lancet. (1986) 36.
159. [154] Ragni, M.V., Gupta, P., Rinaldo, V.R., Kingsley, L.A., Lawrence, A., Spero, J.A. and Lewis, J.H. HIV transmission to female sexual partners of HIV antibody-positive hemophiliacs. Public Health Rep., 103(1) (1988) 54-58.
160. [155] Lederman, M.M., Ratnoff, O.D., Oscar, D., Evatt, B.L., and McDougal, J.S. Acquisition of antibody to lymphadenopathy-associated virus in patients with classic hemophilia (Factor VIII deficiency), Ann. Int. Med. 102 (1985) 753-757.
161. [156] Jaffe, H.W., Sarngadharan, M.G., DeVico, A.L. et al. Infection with HTLV-III/LAV and transfusion-associated Acquired Immunodeficiency Syndrome. J. Am. Med. Assoc., 254(6) (1985) 770-773.
162. [157] Bierling, P., Cordonnier, C., Duedari, N., Vernant, J., Leibowitch, J. and Mathez, D. Lymphadenopathy-associated virus/Human T-lymphotropic virus type III in allogenic bone marrow transplantation. Ann. Int. Med., 104 (1986) 1, 131, Burger, H., Weiser, B., Robinson, W.S. et al. Transmission of lymphadenophy-associated virus/Human T-lymphotropic virus type III in sexual partners, 81 (1986) 5-10.
163. [157] Bierling, P., Cordonnier, C., Duedari, N., Vernant, J., Leibowitch, J. and Mathez, D. Lymphadenopathy-associated virus/Human T-lymphotropic virus type III in allogenic bone marrow transplantation. Ann. Int. Med., 104 (1986) 1, 131, Burger, H., Weiser, B., Robinson, W.S. et al. Transmission of lymphadenophy-associated virus/Human T-lymphotropic virus type III in sexual partners, 81 (1986) 5-10.
164. [158] Ammann, A.J. Etiology of AIDS, J. Am. Med. Assoc., 252 (1984) 10, 1221-1282, Curran, J. W., Lawrence, D.N., Jaffe, H. et al. Acquired Immunodeficiency Syndrome (AIDS) associated with transfusions. N. Eng. J. Med. 310 (1984) 69-75.
165. [158] Ammann, A.J. Etiology of AIDS, J. Am. Med. Assoc., 252 (1984) 10, 1221-1282, Curran, J. W., Lawrence, D.N., Jaffe, H. et al. Acquired Immunodeficiency Syndrome (AIDS) associated with transfusions. N. Eng. J. Med. 310 (1984) 69-75.
166. [159] Ward, J.W., Bush, T.J., Perkins, H.A. et al. The natural history of transfusion-associated infection with human immunodeficiency virus. Factors influencing the rate of progression to disease. N. Engl. J. Med., 321 (1989) 947-952.
167. [160] Blaxhult, A., Granath, F., Lidman, K., Giesecke, J. The influence of age on the latency period to AIDS in people infected by HIV through blood transfusion. AIDS, 4 (1990) 125-129.
168. [161] Msellati, P., Dupon, M., Morlat, P. et al. A cohort study of 89 HIV-1-infected patients contaminated by blood products: Bordeaux 1981-1989. AIDS, 4 (1990) 1105-1109.
169. [162] Kopec-Schrader, E., Tindall, B., Learmont, J., Wylie, B. and Kaldor, J.M., Development of AIDS in people with transfusion-acquired HIV infection. AIDS, 7 (1993) 1009-1013.
170. [163] Goudsmit, P., Paul, D.A., Lange, J.M.A. et al. Expression of Human Immunodeficiency Virus antigen (HIV-Ag) in serum and cerebrospinal fluid during acute and chronic infection. Lancet. (1986) 177-180.
171. [164] Deacon, N.J., Tyskin, A., Solaman, A. et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients, Science, 270 (1995) 988-991.
172. [165] Pinching, A., Weiss, R.A. and Miller, D. AIDS and HIV infection: new perspectives. Br. Med. Bul., 44 (1988) 1, 1-19; see also, Tulane University School of Medicine study reported in Science, 263 (1994) 27.
173. [165] Pinching, A., Weiss, R.A. and Miller, D. AIDS and HIV infection: new perspectives. Br. Med. Bul., 44 (1988) 1, 1-19; see also, Tulane University School of Medicine study reported in Science, 263 (1994) 27.
174. [166] Allain, J.P., LAV infection by blood and blood derivatives. In: Gluckman, J.C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Elsevier, Paris, 1987, pp. 167-171.
175. [167] Duesberg, P.H., Retroviruses as carcinogens and pathogens: expectations and reality. Cancer Res., 47 (1987) 11990-1220.
176. [168] Duesberg, P.H. (letter). Science, 242 (1988) 997-998.
177. [169] Duesberg, P.H. Human Immunodeficiency Virus and Acquired Immunodeficiency Syndrome: correlation but not causation. Proc. Natl. Acad. Sci. USA, 86 (1989) 755-764.
178. [170] Krause, R.M. Koch's postulates and the search for the AIDS agent. Pub. Health Rep., 99 (1984) 3, 291-299.
179. [171] Adams, D.H. and Bell, T.M., Slow Viruses, Reading. Addison-Wesley, 1976.
180. [172] Melbye, M., Biggar, R.J., Ebbesen, P. et al. Long-term seropositivity for Human T-lymphotropic Virus type III in homosexual men without the Acquire Immunodeficiency Syndrome: development of immunologic and clinical abnormalities. Ann. Int. Med., 104 (1986) 496-500.
181. [173] Salahuddin, S.Z., Groopman, J.E., Markhman, P.D. et al. HTLV-III in symptom-free seronegative persons. Lancet. (1984) 1418-1420.
182. [174] Levy, J.A., Pathogenesis of Human Immunodeficiency Virus infection. Microbiol. Rev., 57 (1993) 183-289.
183. [175] Amroziak, J.A., Blackbourn, D.J., Herndier, B.G. et al. Herpes-like sequences in HIV-infected and uninfected Kaposi's Sarcoma patients. Science, 268, (1995) 582-583.
184. [176] Cohen, J., Controversy: Is KS really caused by new Herpesvirus? Science, 268 (1995) 1847-1848.
185. [177] Narayan, O., Sheffer, D., Griffin, D.E., Clements, J. and Hess, J. Lack of neutralizing antibodies to Caprine Arthritis-Encephalitis Lentivirus in persistently infected goats can be overcome by immunization with inactivated Mycobacterium tuberculosis. J. Virol. 49(2) (1984) 349-355.
186. [178] Duesberg, P. HIV and AIDS. Science, 260 (1993) 1705, Lifson, JD, HIV and AIDS. Science, 260 (1993) 1705-1706.
187. [178] Duesberg, P. HIV and AIDS. Science, 260 (1993) 1705, Lifson, JD, HIV and AIDS. Science, 260 (1993) 1705-1706.
188. [179] Allen, A.D., Mathisen, G.E., Glover, N. and Au, J. HIV and AIDS. Science, 260 (1993) 1706-1707.
189. [180] Fauci, A.S., Multifactorial nature of Human Immunodeficieny Virus disease: Implications for theory. Science, 262 (1993) 1011-1018.
190. [181] Cohen, J., Duesberg and critics agree: Hemophilia is the best test. Science, 266, (1994) 1645-1646.
191. [182] Strayer, D.R. and Gillespie, D.H. The nature of organization of retroviral genes in animal cells. Virology Monographs. No. 17, Springer-Verlag, Wien, 1980.
192. [183] Temin, H.M. and Bolognesi, D.P. Where has HIV been hiding? Nature, 362 (1993) 292-293.
193. [184] Paciucc, P.A. and Holland, J.F. Hypothesis: AIDS: AAIDS (Acquired Autoimmune Immunodeficiency Syndrome)? AIDS Res. 3 (1984) 1, 149-155.
194. [185] Buskila, D. and Gladman, D. Musculoskeletal manifestations of infection with Human Immunodeficiency Virus. Rev. Infect. Dis., 12(2) (1990) 223-235.
195. [186] Lipton, S.A. 'HIV displays its coat of arms', Nature, 367 (1994) 113-114.
196. [187] Harrer, T., Harrer, E., Kalams, S.A. et al. Strong cytotoxic T-cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV Type 1 infection. AIDS Res. Human Retroviruses, 12(7), (1996) 585-590.
197. [188] Barnes, D.M., Solo actions of AIDS virus coat. Science, 237 (1987) 971-973.
198. [189] Gurney, M.E., Heinrich, S.P., Lee, M.R. and Yin, H.S. Molecular cloning and expression of neuroleukin, a neurotrophic factor for spinal and sensory neurons. Science, 234 (1986) 566-574.
199. [190] Gyorkey, F., Melnick, J.L. and Gorkey, P. Human Immunodeficiency Virus in brain biopsies of patients with AIDS and progressive encephalopathy. J. Infect. Dis. 155(5) (1987) 870-876.
200. [191] Ho, D.D., Rota, T.R., Schooley et al. Isolation of HTLV-III from CSF and natural tissues of patients with AIDS-related neurological syndromes. In: Gluckman, J. C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Elsevier, Amsterdam, 1987, pp. 211-218.
201. [192] Habeshaw, J., Hounsell, E. and Dalgleish, A. Does the HIV envelope induce a chronic graft-versus-host-like disease? Immunol. Today, 13(6) (1992) 207-210.
202. [193] Ratner, L., Polmar, S.H., Paul, N. and Ruddle, N. Cytotoxic factors secreted by cells infected by Human Immunodeficiency Virus type 1. AIDS Res. Human Retroviruses, 3(2) (1987) 147-155.
203. [194] Levy, J.A., Evans, L., Cheng-Meyer, C. et al. Biologic and molecular properties of the AIDS-associated retrovirus that affect antiviral therapy. In: Gluckman, J.C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Elsevier, Amsterdam, 1987, pp. 31-41.
204. [195] Pantaieo, G., Graziosi, C., Demarest, J.F. et al. HIV infection is active and progressive in lymphoid tissue during the clinically lantent stage of disease. Nature, 362 (1993) 355-358.
205. [196] Embretson, J., Zupancic, M., Ribas, J.L. et al. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature, 362 (1993) 359-362.
206. [197] Broder, C.C. and Berger, E.A., Fusogenic selectivity of the envelope glycoprotein is a major determination of Human Immunodeficiency Virus type 1 tropism for CD4+ T-cell lines vs. primary macrophages. Proc. Natl. Acad. Sci. USA, 92(19) (1995) 9004-9008.
207. [198] Laman, J.D., HIV and AIDS. Science, 260 (1993) 1707-1708.
208. [199] Booth, W., A rebel without a cause of AIDS. Science 334 (1988) 239, 1485-1488.
209. [200] Rubin, H., Is HIV the causative factor in AIDS? Nature, 334 (1988) 201.
210. [201] Ascher, M.S., Sheppard, H.W., Winkelstein, Jr., W., Vittinhoff, E. 'Does drug use cause AIDS?', Nature, 362 (1993) 103-104.
211. [202] Duesberg, P., Does HIV cause AIDS? Acq. Immun. Def. Synd., 2(5) (1989) 514-515.
212. [203] Duesberg, P., Defective viruses and AIDS. Nature, 340 (1989) 515.
213. [204] Duesberg, P. Immunosuppressive behavior, not HIV may be the cause of AIDS. Policy Rev., 53 (1990) 40-51.
214. [205] Duesberg, P., HIV-free AIDS reports (Letter), Science, 257 (1992) 1848.
215. [206] Liversidge, A. AIDS: words from the front. Spin, 1987 (Feb): 56-70.
216. [207] Gallo, R.C. Human tumor and immunodeficiency viruses. AIDS Res. Human Retrovirises. 3 Suppl. 1 (1987) 187-196.
217. [208] Garcia-Blanco, M.A. Molecular basis of latency in pathogenic human viruses. Science, 254 (1992) 815-820.
218. [209] Steel, C.M., Beatson, D., Cuthbert, R.J.G. et al. HLA haplotype A1 B8 DR3 as a risk factor for HIV-related disease. Lancet. (1988) 1185-1188.
219. [210] Namikawa, R., Kaneshima, H., Lieberman, M., Weissman, I.L. and McCune, J.M. Infection of the SCID-hu Mouse by HIV-1. Science, 242 (1988) 1684-1686.
220. [211] Chow, S.A. Vincent, K.A., Ellison, V. and Brown, P.O. Reversal of integration and DNA splicing mediated by integrase of Human Immunodeficiency Virus. Science, 255 (1992) 723-726.
221. [212] Bushman, F.D., Tethering human immunodeficiency virus 1 integrase to a DNA site directs integration to nearby sequences. Proc. Natl. Acad. Sci. USA, 91 (1994) 9233-9237.
222. [213] Muller, H.-P. and Varmus, DNA bending creates favored sites for retroviral integration: an explanation for preferred insertion sites in nucleosomes, EMBO., 13 (1994) 4704-4714.
223. [214] Pruss, D., Bushman, F.D. and Wolffe, A.P., Human immunodeficiency Virus integrase directs integration sites of severe DNA distortion within the nucleosome core. Proc. Natl. Acad. Sci. USA, 91 (1994) 5913-5917.
224. [215] Norieau, F., HIV transmission from monkey to man. Lancet, (1987) 1498-1499.
225. [216] Todaro, G.J. Interspecies transmission of mammalian retroviruses. In: Stephenson, J.R. (Ed.), Molecular Biology of RNA Tumor Viruses. Academic Press, New York, 1980, pp. 47-77.
226. [217] Brack-Werner, R., Barton, D.E., Werner, T., Foellmer, B.E., Leib-Mosch, C., Francke, U., Erfle, V. and Hehlmann, R. Human SSAV-related endogeneous retroviral element: LTR-like sequence and chromosomal localization to 18q21. Genomics, 4 (1989) 68-75.
227. [218] Klein, J., Takahata, N. and Ayala, F.J. MHC polymorphism and human origins. Sci. Am., 269(6) (1993) 78-83.
228. [219] Gustafsson, K., Brunsberg, U., Sigurdardottir, S. and Anderson, L. A phylogenetic investigation of MHC class II DRB genes reveals convergent evolution in the antigen binding site In: Klein J. and Klein D. (Eds.), Molecular Evolution of the Major Histocompatibility Complex. NATO ASI series, Series H: Cell Biology, 59, 1991, pp. 119-130.
229. [220] Holland, J.J., Slow, inapparent and recurrent viruses. Sci. Am., 230(2) (1974) 32-40.
230. [221] Marchalonis, J.J., Immunity in Evolution. Cambridge, Harvard University Press, 1977.
231. [222] Mariotti, S., Sansoni, P., Barbesino, G. et al. Thyroid and other organ-specific autoantibodies in healthy centenarians. Lancet. (1992) 1506-1508.
232. [223] Briggs, D.C., Vaughan, R.W., Welsh, K.I., Myers, A., DuBois, R.M. and Black, C.M. Immunogenetic prediction of pulmonary fibrosis in systemic sclerosis. Lancet, (1991) 661-662.
233. [224] Hoekman, K., Von Blomberg-van der Flier, B.M.E., Wagstaff, J., Drexhage, H.A. and Pinedo, H.M. Reversible thyroid dysfunction during treatment with GM-CSF. Lancet, (1991) 541-542.
234. [225] Cohen, J. Could drugs, rather than a virus be the cause of AIDS? Science, 266, (1994) 1648-1649.
235. [226] Schattner, A. and Rager-Zisman, A. Virus-induced autoimmunity. Rev. Infect. Dis., 12(2) (1990) 204-222.
236. [227] Smith, R.W. AIDS and 'slow viruses'. In: Selikoff, I.J., Teirstein, A.S. and Hirschman, S.Z. (Eds.), Acquired Immune Deficiency Syndrome. Ann. NY Acad. Sci., 437 (1984) 576-607.
237. [228] Golding, H., Robey, F.A., Gates, F.T. III, et al. Identification of homologous regions in human immunodeficiency virus I gp41 and human MHC class II beta1 domain. I. Monoclonal antibodies against the gp41-derived peptide and patients' sera react with native HLA class II antigens, suggesting a role for autoimmunity in the pathogenesis of acquired immune deficiency syndrome. J. Exp. Med. 167 (1988) 914-923.
238. [229] Kopelman, R.G. and Zola-Pazner, S. Association of human immunodeficiency virus infection and autoimmune phenomena. Am. J. Med., 84 (1988) 82-88.
239. [230] Pulgliese, O., Viora, M., Camponeschi, B. et al. A gp120 HIV peptide with high similarity of HLA class II beta chains enhances PPD-specific and autoreactive T-cell activation, Clin. Exp. Immunol., 90(2) (1992) 170-174.
240. [231] Koshino, K., Tokano, Y., Sekigawa, I., Takashaki, Y. and Hashimoto, H., Detection of antibodies to HIV-1 gp41 and HLA class II antigen-derived peptides in SLE patients. Scand. J. Rheumatol., 24(5) (1995) 288-292.
241. [232] Torres, B.A. and Johnson, H.M., Indentification of an HIV-1 Nef. peptide that binds to HLA class II antigens. Biochem. Biophys. Res. Com., 200(2) (1994) 1059-1065.
242. [233] Hill, A.V.S., Allsopp, C.E.M., Kwiatkowski, D. et al. Common West African HLA antigens are associated with protection from severe malaria. Nature, 352 (1991) 595-600.
243. [234] Tiwari, J.L., Terasaki, P.I. HLA and Disease Associations. Springer-Verlag, New York, 1985.
244. [235] Bartl, S., Baltimore, D. and Weissman, I.L., Molecular evolution of the vertebrate immune system. Proc. Natl. Acad. Sci. USA, 91 (1994) 10769-10770.
245. [236] Martin, M.A., Fast-acting slow viruses. Nature, 345 (1990) 572-573.
246. [237] Kestler, H., Kodama, T., Ringler, D. et al. Induction of AIDS in rhesus monkeys by molecularly cloned Simian Immunodeficiency Virus. Science, 248 (1990) 1109-1112.
247. [238] Gotch, F., Nixon, D., Gallimore, A. et al. Cytotoxic T lymphocyte epitopes shared between HIV-1, HIV-2 and SIV. J. Med. Primatol. 22 (1993) 119-123.
248. [239] Garry, R.F. Extensive antigenic mimicry by retrovirus capsid proteins. (Letter) AIDS Res. Human Retroviruses, 6(12) (1990) 1361-1362.
249. [240] McClure, M.O., Sattentau, Q.J., Beverley, P.C.L. et al. HIV infection of primate lymphocytes and conservation of the CD4 receptor. Nature, 330 (1987) 487-489.
250. [241] Parker, R., Acquired Immunodeficiency Syndrome in urban Brazil. Med. Anthropol Qrt. New Ser. 1(2) (1987) 155-175.
251. [242] Montagnier, L., Environmental pathogenesis of Human retroviruses. AIDS Res. Human Retrovviruses, 12(5) (1995) 357-359.
252. [243] Franchini, G. and Reitz, M.S., Phylogenesis and genetic complexity of the nonhuman Primate Retroviridae. AIDS Res. Human Retroviruses, 10 (1994) 1047-1060.
253. [244] Doolittle, R.F. and Feng, D.F. Tracing the origin of retroviruses. Curr. Top. Microbiol. Immunol., 176 (1992) 195-211.
254. [245] Clemetson, D.B., Moss, G.B., Willerford, D.M. et al. Detection of HIV DNA in cervical and vaginal secretions. Prevalence and correlates among women in Nairobi, Kenya. J. Am. Med. Assoc., 269 (1993) 2860-2864.
255. [246] Nair, M.P., Saravolatz, L.D. and Schwartz, S.A., Selective inhibitory effects of stress hormones on natural killer (NK) cell activity of lymphocytes from AIDS patients. Immunol. Invest., 24(5) (1995) 599-689.
256. [247] Levander, O.A., Ager, A.L. Jr. and Beck, M.A., Vitamin E and selenium: contrasting and interacting nutritional determinants of host resistence to parasitic and viral infections. Proc. Nutr. Soc., 54(2) (1995) 475-487.
257. [248] Poss, M., Kreiss, J., Jackson, S. et al. Analysis of transmitted HIV-1 genotypes: studies of commerical sex workers and infants in Kenya. Cold Spring Harbor Symp. Retroviruses, 1995, p. 11.
258. [249] Butler, D., New York researchers question claims of 'first' AIDS case. Nature, 374 (1995) 397; Zhu, T. and Ho, D.D., Was HIV present in 1959?, Nature, 374 (1995) 503-504.
259. [249] Butler, D., New York researchers question claims of 'first' AIDS case. Nature, 374 (1995) 397; Zhu, T. and Ho, D.D., Was HIV present in 1959?, Nature, 374 (1995) 503-504.
260. [250] Nzilambi, N., De Cock, K.M., Forthal, D.N. et al. The prevalence of infection with Human Immunodeficiency Virus over a 10 year period in rural Zaire. N. Engl. J. Med. 316(5) (1988) 276-279.
261. [251] Lightfoot-Klein, H., A Woman's Odyssey into Africa, Harrington Park Press, New York, 1992.
262. [252] Lightfoot-Klein, H., Personal Communication, 1994.
263. [253] Piot, P., Plummer, F.A., Mhalu, F.S. et al. AIDS: an international perspective. Science, 239 (1988) 573-579.
264. [254] Lesbordes, J.L., Chassignol, S., Manaud, F. et al. Malnutrition and HIV infection in children in the Central African Republic. Lancet, (1986) 337-338.
265. [255] Fuchs, D., Hausen, A., Reibnegger, G., Werner, E.R., Dierich, M.P. and Wachter, H. HIV seroconversion in health care workers. J. Am. Med. Assoc., 258(18) (1987) 2525-2526.
266. [256] Olufemi-Williams, A. AIDS: An African Persepctive, CRC Press, Boca Raton, 1992.
267. [257] Zinkernagel, R.M., Cooper, S., Chambers, J. et al. Virus-induced autoantibody response to a transgenic viral antigene. Nature, 345, (1990) 68-71.
268. [258] Chiu, I.M., Callahan, R., Tronick, S.R., Schlom, J. and Aaronson, S.A. Major pol gene progenitors in the evolution of Oncoviruses. Science, 223 (1984) 364-370.
269. [259] O'Donnell, C.D. and Cohen, M. ERV3, a full-length human endogenous provirus: sequence analysis and evolutionary relationships. In: Furmanski, P., Hager, J.C. and Rich, M.A. (Eds.), RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS. Boston, Martinus Nijhoff, 1984, pp. 108-115.
270. [260] Rabson, A.B., Steele, P.E., Repaske, R. and Martin, M.A. Structure and function of human endogenous type C retroviral DNAs. In: Furmanski, P., Hager, J.C. and Rich, M.A. (Eds.), RNA Tumor Viruses, Oncogenes, Human Cancer and AIDS. Martinus Nijhoff, Boston, 1984, pp. 93-107.
271. [261] Kaplan, H.S., Prospects for the etiologic involvement of RNA Tumor viruses in human cancer. In: Stephenson, J.R. (Ed.), Molecular Biology of RNA tumor Viruses. Academic Press, New York, 1980, pp. 485-514.
272. [262] Saag, M.S., Hahn, B.H., Gibbons, J. et al. Extensive variation of Human Immunodeficiency Virus type 1 in vivo. Nature, 334 (1988) 440-444.
273. [263] Fisher, A.G., Ensoli, B., Looney, D. et al. Biologically diverse molecular variants within a single HIV-1 isolate. Nature, 334 (1988) 444-447.
274. [264] Leib-Mosch, C., Bachmann, R., Brack-Werner, R., Werner, T., Wrifle, V. and Helmann, R., Expression and biological significance of human endogenous retroviral sequences. Leukemia, 6 (1992) s3, s72-s75.
275. [265] Maruer, B. and Flugel, R.M. Genomic organization of the Human Spumaretrovirus and its relatedness to AIDS and other Retroviruses. AIDS Res. Human Retroviruses, 4 (1988) 6, 467-472.
276. [266] Chassagne, J., Verelle, P., Fonck, Y. et al. Detection of the lymphadenopathy-associated virus p18 in cells of patients with lymphoid diseases using a monoclonal anitbody. In: Gluckman, J.C. and Vilmer, E. (Eds.), Acquired Immunodeficiency Syndrome. Elsevier, Paris, 1987, pp. 115-120.
277. [267] Haltmeier, M., Seifarth, W., Blush, J. et al. Isolation and characterization of S71-related Human Endogenous Retroviral elements with full-length pol genes. Cold Spring Harbor Symp. Retroviruses, 1995, p. 212.
278. [268] Kubo, Y., Kakimi, K., Higo, K. et al. Conversion of an endogenous retroviral sequence isolated from C57BL/6 mice to a Murine AIDS-inducing sequence by frame-shift mutations, Cold Spring Harbor Symp. Retroviruses, 1995, p. 32.
279. [269] Kitamura, Y., Ayukawa, T., Ishikawa, T. et al. Putative integrase encoded by Human Endogenous Retrovirus K10 has integration activity with various donor sequences. Cold Spring Harbor Symp. Retroviruses, 1995, p. 112.
280. [270] Kanagawa, O., Vaupel, B.A., Gayama, S., Koehler, G. and Kopf, M., Resistence of mice deficient in IL-4 to retrovirus-induced immunodeficiency syndrome (MAIDS). Science, 262 (1993) 240-242.
281. [271] Zhang, J. and Tamin, H.M., Rate and mechanism of nonhomologous recombination during a single cycle of retroviral replication. Science, 255 (1993) 234-238.
282. [272] Swain, A. and Coffin, J.M., Mechanism of transduction by retroviruses. Science, 255 (1992) 841-845.
283. [273] Anon. Prion dimers: a deadly duo? Trends Neurosci., 14(10) (1991) 423-424.
284. [274] Chesebro, B., PrP and the Scrapie agent. Nature, 356 (1992) 560.
285. [275] Via, C.S., Immunopathogenesis of autoimmunity following Human Immunodeficiency Virus infection. In: Cruse, J.M. and Lewis, R.E. (Eds.), Clinical and Molecular Aspects of Autoimmune Disease. Concepts Immunopathol. Series. Basel, 8 (1992) 238-249.
286. [276] Knudson, Jr. A.G. Hereditary cancer, oncogenes, and antioncogenes. Can. Res. 45 (1985) 1427-1443.
287. [277] Cruse, J.M., Lewis, R.E. Autoimmunity in the age of molecular biology. In: Cruse, J.M. and Lewis, R.E. (Eds.), Clinical and Molecular Aspects of Autoimmune Disease. Concepts in Immunopathol. Series, Basel, 8 (1992) 1-17.
288. [278] Varmus, H., Oncogenic transformation, protooncogenes, and tumor suppressor genes. Faculty lecture Series, August 4 and 6th 1992.
289. [279] Morley, D.C., The severe measles of West Africa. Proc. Royal Soc. Med. 57 (1969) 846.
290. [280] Miller, L.H., Howard, R.J., Carter, R., Good, M.F., Nussenzweig, V. and Nussenzweig, R.S., Research toward malaria vaccines. Science, 234 (1986) 1349-1355.
291. [281] Steinbrock, R.T., Paleopathological Diagnosis and Interpretation: Bone Disease in Ancient Populations. Charles C. Thomas, Springfield, 1976.
292. [282] Beneson, A.S. (Ed.), Control of Communicable Diseases in Man. 12th Edn., American Public Health Association, Washington, D.C., 1975.
293. [283] Polednak, A.P., Host Factors in Disease. Charles C. Thomas, Springfield, 1987.
294. [284] Zuckerman, S. and Fulton, J.F., The nomenclature of Primates commonly used in laboratory work. Privately Printed. New Haven, Conn., 1934.
295. [285] Osman Hill, W.C., The use of Primates in biomedical studies: a review of suitable species. In: E.I. Goldsmith and J. Moor-Jankowski (Eds.), Experimental Medicine and Surgery in Primates. Ann. NY. Acad. Sci., 162 (1969) 7-14.
296. [286] Desrosiers, R.C., A finger on the missing link. Nature, 345 (1990) 288-289.
297. [287] Gardner, M.B., Kozak, C.A. and O'Brien. The Lake Casitas wild mouse: evolving genetic resistence to retroviral disease. Trends. Genet., 7 (1991) 22-27.
298. [288] Cohen, J., Can one type of HIV protect against another type?, Science, 268 (1995) 1566.
299. [289] Liu, Rong, Paxton, W.A., Choe, S., Ceradini, D., Martin, S.R. et al., Homozygous-defect in HIV-1 coreceptor accounts for resistence of some multiply-exposed individuals to HIV-1 infection, Cell, 86, Aug. 9 (1996) 367-377.